OR9Q2: A Protein Involved in Cellular Signaling and Disease (G219957)

Target Name: OR9Q2

NCBI ID: G219957

OR9Q2

OR9Q2: A Protein Involved in Cellular Signaling and Disease

OR9Q2 (OR9Q2P) is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and gastrointestinal tract. It is a member of the G-protein-coupled receptor (GPCR) family, which is a large family of transmembrane proteins that play a critical role in cellular signaling.

OR9Q2 is known for its role in the regulation of cell proliferation and differentiation. It is a negative regulator of the T-cell receptor (TCR), which is a critical receptor for the immune system that helps to protect the body against infection and disease. OR9Q2 is also known to play a role in the regulation of cell survival and apoptosis, which are critical processes that help to maintain the integrity of tissues and are necessary for their function.

OR9Q2 is expressed in a variety of tissues and cells, including the brain, where it is expressed in the neuroglial cells, which are the glial cells that support and protect nerve cells. OR9Q2 is also expressed in other tissues, including the heart, lungs, and gastrointestinal tract, where it is involved in the regulation of cell function and growth.

OR9Q2 has been shown to play a critical role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that OR9Q2 is expressed in various types of cancer, including breast, lung, and ovarian cancer. It is also involved in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

In addition to its role in disease, OR9Q2 is also a potential drug target. Studies have shown that OR9Q2 is a good candidate for small molecule inhibitors, which are drugs that can inhibit the activity of OR9Q2. These drugs could be used to treat a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

OR9Q2 is also a potential biomarker for some diseases. For example, studies have shown that OR9Q2 is downregulated in various types of cancer, including breast, lung, and ovarian cancer. This suggests that OR9Q2 may be a useful biomarker for these diseases. Additionally, OR9Q2 is also downregulated in neurodegenerative diseases, which suggests that it may be a useful biomarker for these diseases as well.

In conclusion, OR9Q2 is a protein that is expressed in various tissues of the body and is involved in the regulation of cell proliferation and differentiation. It is a negative regulator of the T-cell receptor and is known to play a critical role in the immune system. OR9Q2 is also involved in the regulation of cell survival and apoptosis and is a potential drug target and biomarker for various diseases. Further research is needed to fully understand the role of OR9Q2 in disease and to develop effective treatments.

Protein Name: Olfactory Receptor Family 9 Subfamily Q Member 2

Functions: Odorant receptor

The "OR9Q2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR9Q2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets